790697-89-1

Upstream product

• 790698-12-3 (S)-4-Bromo-2-(4-methoxy-benzyloxy)-pent-4-en-1-ol 
• 75-47-8 iodoform 
• 790697-96-0 2-[3-(tert-butyl-diphenyl-silanyloxy)-2-(S)-(4-methoxy-benzyloxy)-propyl]acrylic acid 1-(S)-methyl-allyl ester 
• 790697-97-1 3-[3-(tert-butyl-diphenyl-silanyloxy)-2-(4-methoxy-benzyloxy)propyl]-5-methyl-5H-furan-2-one 
• 790698-13-4 2-[3-(tert-butyl-diphenyl-silanyloxy)-2-(S)-(4-methoxy-benzyloxy)propyl]acrylic acid 
• 790697-95-9 (R)-[4-bromo-2-(4-methoxy-benzyloxy)-pent-4-enyloxy]-tert-butyl-diphenyl-silane 
• 790697-94-8 3-[4-bromo-2-(R)-(4-methoxy-benzyloxy)-pent-4-enoyl]-4-(R)-isopropyl-oxazolidin-2-one 
• 790697-98-2 3-[3-hydroxy-2-(4-methoxy-benzyloxy)propyl]-5-methyl-5H-furan-2-one 

Downstream Products

• 790698-17-8 (S)-3-[(R)-7-((2R,5S)-5-{(1S,4R)-1,4-Bis-methoxymethoxy-4-[(2R,5R)-5-((R)-1-methoxymethoxy-tridecyl)-tetrahydro-furan-2-yl]-butyl}-tetrahydro-furan-2-yl)-2-(4-methoxy-benzyloxy)-heptyl]-5-methyl-5H-furan-2-one 
• 130818-48-3 (+)-gigantecin 
• 892557-92-5 (S)-3-[(R)-9-{(2R,5S)-5-[(1S,4S)-4-((2S,5R,6S)-5-Benzyloxy-6-decyl-tetrahydro-pyran-2-yl)-4-hydroxy-1-methoxymethoxy-butyl]-tetrahydro-furan-2-yl}-2-(4-methoxy-benzyloxy)-nonyl]-5-methyl-5H-furan-2-one 
• 790698-11-2 3-[7-(5-(S)-{1-(S),4-(R)-bis-methoxymethoxy-4-[5-(R)-(1-(R)-methoxymethoxy-tridecyl)tetrahydrofuran-2-(R)-yl]butyl}tetrahydrofuran-2-(S)-yl)-2-(R)-(4-methoxybenzyloxy)hept-3-en-5-ynyl]-5-(S)-methyl-5H-furan-2-one 

Relevant academic research and scientific papers

Enantioselective total synthesis of (+)-gigantecin: Exploiting the asymmetric glycolate aldol reaction

The enantioselective synthesis of the potent, selective, cytotoxic, annonaceous acetogenin, (+)-gigantecin, has been completed. An asymmetric glycolate aldol serves to establish the stereocenters at C13,14 and at C21,22. A Carreira asymmetric acetylide ad